Show source-provided references
3. Importance and Limitations of Chemotherapy Among the Available Treatments for Gastrointestinal Tumours
4. Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives
8. Peptide-Based Therapeutics for Oncology
13. Tornesello, A.L., Borrelli, A., Buonaguro, L., Buonaguro, F.M., and Tornesello, M.L. (2020). Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities. Molecules, 25.
10.3390/molecules25122850 ↗15. Cheah, Y.H., Liu, C.Y., Yip, B.S., Wu, C.L., Peng, K.L., and Cheng, J.W. (2022). Strategy to Enhance Anticancer Activity and Induced Immunogenic Cell Death of Antimicrobial Peptides by Using Non-Nature Amino Acid Substitutions. Biomedicines, 10.
10.3390/biomedicines10051097 ↗16. The antimicrobial peptide defensin cooperates with tumour necrosis factor to drive tumour cell death in Drosophila
10.7554/eLife.45061 ↗18. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3
20. Piller, P., Wolinski, H., Cordfunke, R.A., Drijfhout, J.W., Keller, S., Lohner, K., and Malanovic, N. (2022). Membrane Activity of LL-37 Derived Antimicrobial Peptides against Enterococcus hirae: Superiority of SAAP-148 over OP-145. Biomolecules, 12.
10.3390/biom12040523 ↗26. Designing effective anticancer-radiopeptides. A Molecular Dynamics study of their interaction with model tumor and healthy cell membranes
10.1016/j.bbamem.2018.05.021 ↗32. New insights into the influence of monofluorination on dimyristoylphosphatidylcholine membrane properties: A solid-state NMR study
10.1016/j.bbamem.2017.12.002 ↗33. Helix Fraying and Lipid-Dependent Structure of a Short Amphipathic Membrane-Bound Peptide Revealed by Solid-State NMR
10.1021/acs.jpcb.8b02661 ↗34. Polymorphism of the bilayer membranes in the ordered phase and the molecular origin of the lipid pretransition and rippled lamellae
10.1016/0005-2736(91)90335-6 ↗35. Yeagle, P. (1992). The structure of biological membranes. The Mesomorphic Phase Behavior of Lipid Bilayers, CRC Press.
37. Rojewska, M., Smułek, W., and Kaczorek, E. (2021). Langmuir Monolayer Techniques for the Investigation of Model Bacterial Membranes and Antibiotic Biodegradation Mechanisms. Membranes, 11.
10.3390/membranes11090707 ↗38. Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development
10.4103/0975-7406.76461 ↗39. Charcosset, C., and Sebaaly, C. (2019). Lipid Membrane Models for Biomembrane Properties Investigation. Current Trends and Future Developments on (Bio-) Membranes, Elsevier.
41. Interaction between drug loaded polyaspartamide-polylactide-polysorbate based micelles and cell membrane models: A calorimetric study
10.1021/mp100445k ↗43. β-phase formation of poly (9,9-dioctylfluorene) induced by liposome phospholipid bilayers
10.1021/jp2010666 ↗44. Aragón-Muriel, A., Ausili, A., Sánchez, K., Rojas, A.O.E., Londoño Mosquera, J., Polo-Cerón, D., and Oñate-Garzón, J. (2019). Studies on the Interaction of Alyteserin 1c Peptide and Its Cationic Analogue with Model Membranes Imitating Mammalian and Bacterial Membranes. Biomolecules, 9.
10.3390/biom9100527 ↗45. Modeling specific heat transient anomalies during permeation of liposomes by water-soluble substances
10.1006/jcis.1997.5315 ↗47. Investigation of Drug for Pulmonary Administration−Model Pulmonary Surfactant Monolayer Interactions Using Langmuir−Blodgett Monolayer and Molecular Dynamics Simulation: A Case Study of Ketoprofen
10.1021/acs.langmuir.9b02412 ↗48. Davies, H.L., and Ridel, E.K. (1961). Interfacial Phenomenon, Academic Press.